Tag: Security

Browse our exclusive articles!

‘ChatGPT App Now Available for Download on iPhone and iPad’

Access ChatGPT's AI chatbot services on iOS devices with the official app now available on the App Store. Get real-time information and voice recognition support for free. Plus subscribers can access advanced features. Beware of third-party copies. OpenAI reviews chats so avoid sensitive information. Only available in the US for now.

Latest Developments in Generative AI

Stay up-to-date with the ever-evolving field of generative AI. TechCrunch+ has got you covered with insightful articles on the latest breakthroughs and how companies can leverage these new technologies for success. Join us on this exciting AI journey!

Snapchat introduces ‘My AI Snaps’ generative AI feature for paid subscribers

Discover Snapchat's My AI Snaps feature, which uses generative AI to supply users with an amusing Snap response. Although it's a fun addition, there may be privacy and security concerns for teens. With over 280 million monthly active users globally, Snapchat's innovative approach to social media has made it one of the most popular apps in the world.

Conquering the Data Dilemma with Zluri Co-founder on ChatGPT

Are AI chatbots like ChatGPT secure enough for sensitive information? Co-founder of Zluri, Sethu Meenakshisundaram, discusses privacy and security concerns companies need to address.

How ChatGPT and large language models are transforming gastroenterology research in Nature Reviews Gastroenterology and Hepatology

LLMs and ChatGPT are revolutionizing gastroenterology by paving the way for faster, cheaper clinical trials and aiding drug discovery. But reliability and risks must be weighed. ChatGPT's AI chatbot improves patient engagement for better outcomes.

Popular

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.

Pioneering Research Uncovers Vital Biomarker for Orbital Inflammation

An in-depth study reveals HLF as a potential biomarker for orbital inflammation, offering new insights for diagnosis and treatment strategies.

Subscribe

spot_imgspot_img